1-17 of 17
Yue-Yun Lai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Wen-Jing Yu, Ying Wu, Qi Chen, Xiaolu Zhu, Xu-Ying Pei, Jin-Song Jia, Jing Wang, Xiao-Su Zhao, Ying-Jun Chang, Yue-Yun Lai, Hong-Xia Shi, Guo-Rui Ruan, Ya-Zhen Qin, Xiao-Hong Liu, Xiao Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1525.
https://doi.org/10.1182/blood-2023-184665
Published: 2023
Journal Articles

Interferon-a-2b As a Maintenance Therapy Significantly Improves Disease-Free Survival in Patients with Low-Risk Acute Myeloid Leukemia

Xiaohong Liu, Wenbing Duan, Jing Wang, MD, Jinsong Jia, Lizhong Gong, Shen-ye Lu, MD, Xiaosu Zhao, PhD, Ying-Jun Chang, Yue-Yun Lai, Hongxia Shi, Yu Wang, Chenhua Yan, Xiaojun Huang, MD, Hao Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3823.
https://doi.org/10.1182/blood-2019-128505
Published: 2019
Journal Articles

Interferon May Help Control the Recurrence of Chronic Myeloid Leukemia after Discontinuation of Tyrosine Kinase Inhibitor

Jun Kong, MD, Xiao-Hong Liu, Ya-Zhen Qin, Hong-Xia Shi, Yue-Yun Lai, Xiao-Jun Huang, Hao Jiang
Journal: Blood
Blood (2018) 132 (Supplement 1): 4270.
https://doi.org/10.1182/blood-2018-99-119063
Published: 2018
Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Clinical Trials & Observations
Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai
Journal: Blood
Blood (2018) 131 (26): 2987–2989.
https://doi.org/10.1182/blood-2018-02-834051
Published: 2018
Includes: Supplemental data
Journal Articles

Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients

Yuan Kong, Xie-Na Cao, Xiao-Hui Zhang, Min-Min Shi, Yue-Yun Lai, Yu Wang, Lan-Ping Xu, Ying-Jun Chang, Xiao-Jun Huang
Journal: Blood
Blood (2018) 131 (11): 1219–1233.
https://doi.org/10.1182/blood-2017-09-807248
Published: 2018
Includes: Supplemental data
Journal Articles

Atorvastatin May Reverse Corticosteroid-Resistant Immune Thrombocytopenia Via Improving Impaired Bone Marrow Endothelial Cells

Yuan Kong, Xie-Na Cao, Xiaohui Zhang, MD, Min-Min Shi, Yue-Yun Lai, Yu Wang, Lan-Ping Xu, Ying-Jun Chang, Xiao-Jun Huang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 232.
https://doi.org/10.1182/blood.V130.Suppl_1.232.232
Published: 2017
Journal Articles

Comparison of the Outcome between Newly Diagnosed Patients in the Accelerated Phase and Chronic Phase with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors

Qian Jiang, MD, Lu Yu, MD, Ya-Zhen Qin, Yue-Yun Lai, Xiao-Jun Huang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2876.
https://doi.org/10.1182/blood.V130.Suppl_1.2876.2876
Published: 2017
Journal Articles

Overexpression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow As a Novel Biomarker in Adult B-Cell Acute Lymphoblastic Leukemia

Shu-Juan Wang, Wei-Min Wang, Wen-Yi Lu, Ya-Zhen Qin, Yue-Yun Lai, Yan-Rong Liu, Xiao-Jun Huang, Kai-Yan Liu, Guo-Rui Ruan
Journal: Blood
Blood (2016) 128 (22): 5271.
https://doi.org/10.1182/blood.V128.22.5271.5271
Published: 2016
Journal Articles

Janus Kinase Inhibition By Ruxolitinib Combined with Nilotinib Has Superior Anti-Leukemia Propagating Cells Effect in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan Kong, MD PhD, Yi-Lin Wu, Yang Song, Min-Min Shi, Ya-Zhen Qin, Yue-Yun Lai, Hao Jiang, MD, Qian Jiang, Xiao-Jun Huang
Journal: Blood
Blood (2016) 128 (22): 4023.
https://doi.org/10.1182/blood.V128.22.4023.4023
Published: 2016
Journal Articles

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Ya-Zhen Qin, Honghu Zhu, Qian Jiang, Hao Jiang, Le-Ping Zhang, Jin-Lan Li, Ling-Di Li, Yan-Rong Liu, Yue-Yun Lai, Hong-Xia Shi, Bin Jiang, MD, Xiao-Jun Huang, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1000.
https://doi.org/10.1182/blood.V124.21.1000.1000
Published: 2014
Journal Articles

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan kong, MD, PhD, Ying-Jun Chang, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Qian Jiang, Hao Jiang, Ya-Zhen Qin, MS, Jing Wang, Hong-Hu Zhu, MD, Yue-Yun Lai, Lanping Xu, Dai-Hong Liu, MD, PhD, Xiao-Jun Huang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 354.
https://doi.org/10.1182/blood.V122.21.354.354
Published: 2013
Journal Articles

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Clinical Trials & Observations
Hong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, Dai-Hong Liu, Hao Jiang, Huan Chen, Qian Jiang, Lan-Ping Xu, Jin Lu, Wei Han, Li Bao, Yu Wang, Yu-Hong Chen, Jing-Zhi Wang, Feng-Rong Wang, Yue-Yun Lai, Jun-Yue Chai, Li-Ru Wang, Yan-Rong Liu, Kai-Yan Liu, Bin Jiang, Xiao-Jun Huang
Journal: Blood
Blood (2013) 121 (20): 4056–4062.
https://doi.org/10.1182/blood-2012-11-468348
Published: 2013
Includes: Supplemental data
Journal Articles

Chronic Myelogenous Leukemia Patients with Highly Nilotinib-Resistant BCR-ABL Mutations Demonstrate Similar Efficacy to Dasatinib, but Have a Higher Likelihood of Developing New Mutations in the Event of Clinical Resistance

Qian Jiang, MD, Ya-Zhen Qin, MS, Yue-Yun Lai, MD, Bin Jiang, MD, Hao Jiang, Hong-Xia Shi, MD, Xiao-Jun Huang, MD
Journal: Blood
Blood (2012) 120 (21): 3755.
https://doi.org/10.1182/blood.V120.21.3755.3755
Published: 2012
Journal Articles

The PRAME and WT1 Transcripts Constitute a Good Molecular Marker Combination for Monitoring Minimal Residual Disease in Myelodysplastic Syndromes

Yazhen Qin, Honghu Zhu, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Hong-Xia Shi, Yue-yun Lai, Lan-Ping Xu, MD, Daihong Liu, Xiaojun Huang
Journal: Blood
Blood (2012) 120 (21): 3853.
https://doi.org/10.1182/blood.V120.21.3853.3853
Published: 2012
Journal Articles

Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Bin Jiang, Xiao-hui Zhang, Yu Wang, Shan-Shan Chen, Xiao-Dong Mo, Xiang-Yu Zhao, Huan Chen, Yu-Hong Chen, Wei Han, Hao Jiang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Hong-Xia Shi, Meng Lv, Xiao Jun Huang
Journal: Blood
Blood (2011) 118 (21): 162.
https://doi.org/10.1182/blood.V118.21.162.162
Published: 2011
Journal Articles

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

Clinical Trials & Observations
Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Shan-Shan Chen, Bin Jiang, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-Hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-Yun Lai, Xiao-Jun Huang
Journal: Blood
Blood (2011) 117 (11): 3032–3040.
https://doi.org/10.1182/blood-2010-09-308510
Published: 2011
Journal Articles

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kaiyan Liu, MD, PhD, Shan-Shan Chen, Bin Jiang, MD, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Xiao Jun Huang
Journal: Blood
Blood (2010) 116 (21): 2347.
https://doi.org/10.1182/blood.V116.21.2347.2347
Published: 2010